Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
13.76
-0.13 (-0.94%)
May 20, 2026, 12:49 PM CST

SHE:002275 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,118990.991,0501,0581,2661,478
Short-Term Investments
---43.4--
Trading Asset Securities
621.47730.31626.15304.69161.24221.77
Cash & Short-Term Investments
1,7391,7211,6761,4061,4271,699
Cash Growth
-11.92%2.72%19.17%-1.45%-16.03%-2.47%
Accounts Receivable
478.73290.05527.3458.33542.51413.03
Other Receivables
21.0898.43118.064.3957.589.1
Receivables
499.81388.47645.36462.72600.09422.13
Inventory
220.69203.26208.29255.96244.9284.15
Other Current Assets
75.1150.8735.1871.1725.0648.4
Total Current Assets
2,5352,3642,5652,1962,2972,454
Property, Plant & Equipment
1,0991,1091,1111,1551,2271,313
Long-Term Investments
77.79147.43296.89299.09132.614.21
Goodwill
5.75.75.75.75.75.7
Other Intangible Assets
132.77134.81141.55153.56168.28178.36
Long-Term Deferred Tax Assets
6.277.1210.29.338.5311.35
Long-Term Deferred Charges
94.7796.16102.44117.04125.76128.8
Other Long-Term Assets
369.07393.86---0.03
Total Assets
4,3204,2584,2323,9363,9654,096
Accounts Payable
219.5185.76191.55201.38133.92180.24
Accrued Expenses
16.1533.56184.85160.61160.45123.86
Short-Term Debt
115.2260.22325.26274.2140.01251.68
Current Portion of Long-Term Debt
-46.06103.3104.54107.5733.04
Current Portion of Leases
--14.7214.7211.819.52
Current Income Taxes Payable
49.9435.4238.6325.9571.7938.13
Current Unearned Revenue
114.5598.2298.0675.99170.01132.79
Other Current Liabilities
123.62125.1439.1136.4551.3859.98
Total Current Liabilities
638.97784.39995.46893.83846.94829.23
Long-Term Debt
244.63180.91121.573.92128.03226.93
Long-Term Leases
25.1626.5928.8660.9578.4587.93
Long-Term Unearned Revenue
82.770.2363.1589.0497.85111.22
Long-Term Deferred Tax Liabilities
000.15-0.330.73
Other Long-Term Liabilities
5.055.0513.321.34--
Total Liabilities
996.511,0671,2221,1191,1521,256
Common Stock
587.57587.57587.57587.57587.57590.2
Additional Paid-In Capital
672.09672.09672.09669.24638.76685.78
Retained Earnings
2,0521,8951,7811,5831,5731,767
Treasury Stock
------204
Comprehensive Income & Other
11.936.78-31.12-22.7214.130.64
Shareholders' Equity
3,3243,1913,0102,8172,8132,840
Total Liabilities & Equity
4,3204,2584,2323,9363,9654,096
Total Debt
384.99513.78593.63528.33465.88609.1
Net Cash (Debt)
1,3541,2081,082877.86961.071,090
Net Cash Growth
3.06%11.59%23.27%-8.66%-11.86%-18.50%
Net Cash Per Share
2.302.061.851.501.631.90
Filing Date Shares Outstanding
592.17590.23587.57587.57587.57575.27
Total Common Shares Outstanding
592.17590.23587.57587.57587.57575.27
Working Capital
1,8961,5801,5691,3021,4501,625
Book Value Per Share
5.615.415.124.794.794.94
Tangible Book Value
3,1853,0512,8632,6582,6392,656
Tangible Book Value Per Share
5.385.174.874.524.494.62
Buildings
--1,000993.15997.121,053
Machinery
--773.59775.0676.8676.54
Construction In Progress
--69.5421.2461.66105.26
Source: S&P Global Market Intelligence. Standard template. Financial Sources.